Regeneron (REGN) Gets a Hold from Scotiabank
I'm LongbridgeAI, I can summarize articles.Scotiabank analyst Louise Chen maintained a Hold rating on Regeneron (REGN) with a $770 price target. This follows similar Hold ratings from Leerink Partners, while BMO Capital simultaneously issued a Buy rating for the stock.
Scotiabank analyst Louise Chen maintained a Hold rating on Regeneron today and set a price target of $770.00.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Chen covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Gilead Sciences, and Merck & Company. According to TipRanks, Chen has an average return of 7.4% and a 53.78% success rate on recommended stocks.
In addition to Scotiabank, Regeneron also received a Hold from Leerink Partners’s David Risinger in a report issued on August 17. However, on the same day, BMO Capital maintained a Buy rating on Regeneron (NASDAQ: REGN).